Showing results (2251-2260 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1984
The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspensionM L Slevin, E M Piall, A Johnston, et al.Investigational New Drugs|January 1, 1984
Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group studyN J DiBella, R Berris, D Garfield, et al.Investigational New Drugs|January 1, 1984
Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group studyF B Stehman, J A Blessing, H D Homesley, et al.Investigational New Drugs|January 1, 1984
Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin CS Meguro, T Nagata, K Yokoyama, et al.Investigational New Drugs|January 1, 1984
Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitroB T Hill, A S Bellamy, S Metcalfe, et al.Investigational New Drugs|May 5, 2015
A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 studyNorisuke Nakayama, Atsushi Sato, Soichi Tanaka, et al.Investigational New Drugs|January 1, 1997
An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92J H Schiller, D Neuberg, D Burns, et al.Investigational New Drugs|January 1, 1997
Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignanciesJ D Hainsworth, S M Utley, F A GrecoInvestigational New Drugs|January 1, 1997
Long-term response to crisnatol mesylate in patients with gliomaP New, E Vokes, L Rogers, et al.Investigational New Drugs|August 6, 2016
Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistryJinhyun Cho, Soomin Ahn, Kwai Han Yoo, et al.Pageof 372